Yiming Chen

Mr. Yiming Chen


Research Focus & Metrics

Academic Career Length

3Years (2024-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
2 February 2025 in Sexual Medicine
Verified
Journal Article
Open access
BZBo Zhang
Bo Zhang
YGYi Gu
Yi Gu
YCYiming Chen
Yiming Chen
WXWei Xia
Wei Xia
NSNaiyuan Shao
Naiyuan Shao
XFXingliang Feng
Xingliang Feng
Background: The C-reactive protein-triglyceride glucose index (CTI) is a recently introduced index designed to simultaneously assess inflammation (via CRP) and insulin resistance (via the triglyceride-glucose index, TyG), both of which are recognized risk factors for declining testosterone levels in men. Aim: This study investigates the association between CTI and low testosterone levels in American adult men, aiming to evaluate CTI as a predictor of low testosterone level. Methods: Data from the 2015–2016 NHANES were used in this cross-sectional study, including men aged 20 and older. Multivariate linear and logistic regression models were employed to analyze the relationship between CTI, total testosterone levels, and the risk of low testosterone level. Receiver operating characteristic (ROC) curves were generated to assess the predictive performance of CTI for low testosterone level. Outcomes: The primary outcome was testosterone levels, with low testosterone level defined as a serum testosterone level below 300 ng/dL in adult men. Results: Among 878 participants, 189 had low testosterone level. The mean CTI was significantly higher in the low testosterone level group (9.39 ± 0.09) compared to the non- low testosterone level group (8.62 ± 0.05; P < .0001). After adjusting for covariates, higher CTI was significantly associated with lower total testosterone levels (β = –44.6, 95% CI: –66.34, –22.87, P < .001) and increased low testosterone level risk (OR = 1.84, 95% CI: 1.31, 2.57, P = .002). ROC analysis showed that CTI (AUC = 0.7357, 95% CI: 0.6975, 0.7739) outperformed TyG and VAI in predicting low testosterone level, highlighting its potential clinical value in assessing low testosterone status. Clinical Implications: Timely monitoring of testosterone levels in individuals with elevated CTI is clinically significant. Additionally, for those with TD, regular assessment of CTI may help in preventing future cardiovascular complications. Strengths and limitations: This study is the first to explore the relationship between CTI and low testosterone using a large sample from the NHANES database. However, due to the cross-sectional design, causal inference regarding CTI and low testosterone level cannot be drawn. Conclusions: CTI appears to be a more effective predictor of low testosterone level than TyG, CRP, or VAI, suggesting its usefulness as a simple, low-cost indicator for early TD risk assessment. Further research is needed to verify its clinical applicability across diverse populations.

24 February 2025 in BMC Women's Health
Verified
Journal Article
Open access
PDF file
BZBo Zhang
Bo Zhang
YGYi Gu
Yi Gu
YLYuanyuan Li
Yuanyuan Li
YCYiming Chen
Yiming Chen
XFXingliang Feng
Xingliang Feng
Overactive bladder (OAB) and female sexual dysfunction (FSD) are both common problems in women, but the association between OAB and FSD lacks a large sample study. The purpose of this cross-sectional study was to investigate the association between OAB and FSD. Data for this study were obtained from the 2007–2016 National Health and Nutrition Examination Survey (NHANES) for women aged 20–59 years. OAB was qualified with the aid of the overactive bladder symptom score (OABSS), which was obtained by adding the nocturia score and the urge urinary incontinence score, and participants with a total score ≥ 3 were considered to suffer from OAB. The FSD was defined as a sexual frequency of less than 12 times per year. After adjusting for covariates including basic demographic information, social information (e.g., marital status), gynecological (e.g., abnormal menstruation), and significant medical comorbidities, the association between OAB and FSD was assessed using survey-weighted logistic regression mode. In addition, subgroup analysis and sensitivity analysis were used to further assess the reliability of the findings. A total of 5590 women aged 20–59 were eligible in the final analysis from 2007 to 2016 NHANES. 30.43% of participants (n = 1701) were identified as FSD reporting sexual frequency of 0–11 times/year, while 69.57% of participants (n = 3889) were identified as normal female sexual function reporting sexual frequency > 11 times/year. We performed logistic regression analysis to examine the association between OAB and FSD. The results demonstrated that participants with OAB (OABSS < 3) were 23% more likely to report lower sexual frequency (≤ 11) than those without OAB (OABSS ≥ 3) after adjusting fully for demographics, social history, gynecologic history and significant medical conditions (OR: 1.23, 95%CI: 1.01–1.49, P = 0.040). The study demonstrated the positive association between OAB and FSD measured by low sexual frequency among women 20–59 years old in the U.S. population; it is necessary to perform more comprehensive cohort studies to gain more profound understanding of the association between them.

10 March 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
WXWei Xia
Wei Xia
PXPinpeng Xie
Pinpeng Xie
QZQianfeng Zhuang
Qianfeng Zhuang
MZMingran Zhang
Mingran Zhang
NSNaiyuan Shao
Naiyuan Shao
XFXingliang Feng
Xingliang Feng
Testosterone deficiency (TD) is a globally recognized health concern, closely linked to disruptions in uric acid and lipid metabolism. Recently, the uric acid to high-density lipoprotein cholesterol ratio (UHR) has emerged as a comprehensive index for assessing the impact of inflammation and metabolic disturbances on disease risk. Therefore, we intended to explore the association of UHR with total testosterone levels and the risk of TD among US male adults. The analysis was based on data from the National Health and Nutrition Examination Survey (NHANES) conducted between January 2011 and December 2016. All eligible participants were males aged 20 and older who had complete data for UHR and testosterone levels. The associations between UHR and total testosterone levels and the risk of TD were examined using weighted multivariable linear and logistic regression analysis, respectively. To visually demonstrate the linear relationship between them, weighted regression using generalized additive models and smooth curve fits were applied. Furthermore, subgroup analyses with interaction tests were executed to evaluate the stability of the outcomes. Finally, a total of 2,844 men were enrolled in the study with the weighted mean age of 47.72 ± 0.42 years. Of these, 592 were diagnosed with TD. After controlling for potential confounders, the continuous UHR exhibited a positive linear correlation with the risk of TD (OR = 1.08, 95%CI: 1.04–1.11, P < 0.001) and a negative linear correlation with total testosterone levels (β=-7.82, 95%CI: -10.47 to -5.17, P < 0.0001). When UHR was categorized into quartiles, with Q1 as the reference, participants in Q4 had significantly lower total testosterone levels (β = -96.64, 95% CI: -129.39 to -63.90, P < 0.0001) and a higher risk of TD (OR = 2.35, 95%CI: 1.45–3.80, P = 0.001). These associations remained stable in subgroup analyses without significant interaction (all P for interaction > 0.05). The study indicates that, among adult males, higher UHR is negatively correlated with total testosterone levels and positively associated with the risk of TD. This suggests its potential value for early disease diagnosis and intervention. However, further clinical studies are needed to validate these findings.

20 November 2024 in International Journal Of Impotence Research
Verified
Journal Article
Closed access
PDF file
XFXingliang Feng
Xingliang Feng
NJNuo Ji
Nuo Ji
BZBo Zhang
Bo Zhang
WXWei Xia
Wei Xia
YCYiming Chen
Yiming Chen

27 February 2026 in Medicine
Verified
Journal Article
Open access
YSYifan Shao
Yifan Shao
XFXingliang Feng
Xingliang Feng
YCYiming Chen
Yiming Chen
GZGuoyang Zhang
Guoyang Zhang
YLYu Liu
Yu Liu
QZQianfeng Zhuang
Qianfeng Zhuang
Gallstone disease is a common gastrointestinal disorder influenced by lipid metabolism and systemic inflammation. The remnant cholesterol inflammatory index (RCII), derived from remnant cholesterol (RC) and high-sensitivity C-reactive protein, integrates both components, yet its relationship with gallstones remains unclear. This study aimed to investigate the association between the RCII and gallstone disease in a nationally representative US population. We conducted a cross-sectional analysis using data from 2120 adults in the 2017 to 2020 cycle of the National Health and Nutrition Examination Survey. Gallstone status was based on self-reported physician diagnosis. RC (mg/dL) was estimated using the following formula: RC = TC − (LDL-C + HDL-C). RCII was calculated as RC × hs-CRP/10. Multivariable logistic regression and receiver operating characteristic curve analyses were performed using a complex survey design. Among the participants, 240 reported a history of gallstone disease. In adjusted logistic regression models, each unit increase in log-transformed RCII was associated with a 95% higher odds of gallstone disease (odds ratio: 1.95; 95% confidence interval: 1.62–2.35; P < .0001). Compared with the lowest quartile of RCII, the highest quartile had a significantly increased risk (odds ratio: 4.48; 95% confidence interval: 2.67–7.52; P < .001), with a clear dose-response trend ( P for trend < .001). Receiver operating characteristic analysis revealed that RCII had the highest area under the curve (0.696), with a sensitivity of 52.7% and specificity of 75.8% at the optimal cutoff point. Higher RCII levels are independently associated with gallstone disease. As an integrated marker of lipid-related inflammation, RCII may serve as a potential risk indicator for gallstone formation.

6 January 2025 in BMC Public Health
Verified
Journal Article
Open access
PDF file
YMYangyang Mei
Yangyang Mei
BZBo Zhang
Bo Zhang
XWXiaogang Wang
Xiaogang Wang
RXRenfang Xu
Renfang Xu
WXWei Xia
Wei Xia
XFXingliang Feng
Xingliang Feng
Metabolic health is closely related to testosterone levels, and the cardiometabolic index (CMI) is a novel metabolic evaluation metric that encompasses obesity and lipid metabolism. However, there is currently a lack of research on the relationship between CMI and testosterone, which is the objective of this study. This study utilized data from the National Health and Nutrition Examination Survey (NHANES) cycles from 2011 to 2016. Only adult males who completed physical measurements, lipid metabolism assessments, and testosterone measurements were included in the final analysis. The exposure variable CMI was analyzed both as a continuous variable and a categorical variable divided into quartiles. Testosterone was measured using the isotope dilution liquid chromatography-tandem mass spectrometry technique. Linear and logistic regression analyses were used to explore the relationship between CMI and total testosterone (TT) levels, as well as the risk of testosterone deficiency (TD). Smooth curve fittings were employed to visualize their linear relationships. Subgroup analyses were conducted to evaluate the stability of our results across different participant characteristics. Finally, ROC analysis was used to assess the performance of CMI in predicting TD. A total of 2,747 participants were included in the analysis, including 552 with TD (20.10%). The average CMI of the sample was 1.59 ± 0.03, with TD participants having a higher CMI of 2.18 ± 0.08 compared to non-TD participants at 1.46 ± 0.03. Corresponding testosterone levels were 223.79 ± 3.69 ng/dL and 508.36 ± 5.73 ng/dL, respectively. After adjusting for all covariates, participants with higher CMI showed lower TT (β = -23.84, 95% CI: -33.94, -13.74, p < 0.0001) and a higher risk of TD (OR = 1.26, 95% CI: 1.08, 1.48, p = 0.01). When CMI was categorized into quartiles with Q1 as the reference, participants in Q4 exhibited significantly lower TT (β = -74.04, 95% CI: -106.01, -42.08, p < 0.0001) and a higher risk of TD (OR = 2.34, 95% CI: 1.18, 4.64, p = 0.02). Smooth curve fittings indicated a linear relationship between these variables. Subgroup analyses confirmed the stability of these associations across different population characteristics. ROC curve analysis demonstrated that CMI had good predictive performance for TD with a cut-off value of 1.126 and an AUC (95% CI) of 0.673 (0.649, 0.700). CMI is associated with lower TT and a higher risk of TD, and it can predict the risk of TD. Using CMI for early detection and timely intervention could reduce the disease burden and promote reproductive health. Further prospective studies with large sample sizes are needed to validate these findings.